Next Article in Journal
Synthesis of Oxadiazole-Thiadiazole Hybrids and Their Anticandidal Activity
Next Article in Special Issue
Phenolic Content and Antioxidant Activity in Raw and Denatured Aqueous Extracts from Sprouts and Wheatgrass of Einkorn and Emmer Obtained under Salinity
Previous Article in Journal
Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory
Previous Article in Special Issue
Critical Review on the Significance of Olive Phytochemicals in Plant Physiology and Human Health
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neuraminidase Inhibitory Activity and Constituent Characterization of Fagopyrum dibotrys

1
Institute of Medicinal Plant Development, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100193, China
2
Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
*
Authors to whom correspondence should be addressed.
Submission received: 21 October 2017 / Revised: 8 November 2017 / Accepted: 15 November 2017 / Published: 18 November 2017

Abstract

:
This study aimed to identify a new biological activity of the widely distributed species Fagopyrum dibotrys. Four F. dibotrys extracts (ethyl acetate (EA), petroleum ether (P), ethanol (E), and water (W)) were explored for their anti-neuraminidase (NA) activity. A total of 32 compounds were identified using UHPLC-Q-Exactive Orbitrap HRMS in the EA extract, which had the best NA inhibitory effects. We used the docking data for supporting compounds’ anti-neuraminidase activity. Among them, five compounds including one flavonoid, three organic acids, and one glucoside were discovered for the first time in F. dibotrys. Docking studies and NA activity assay revealed the remarkable NA inhibitory activity of eight components in EA extract, especially rutin, hesperidin, procyanidin B2, and quercitrin. Therefore, F. dibotrys could be used to develop anti-influenza drugs.

1. Introduction

Fagopyrum dibotrys is an important crude drug and functional food that has been widely used in traditional Chinese medicine (TCM) [1]. It mainly grows in China, Vietnam, India, and Thailand [2]. The herb, which has been recorded in the Chinese Pharmacopoeia since 1977, is a functional food and has been approved by National Health and Family Planning Commission of the People’s Republic of China (NHFPC). It also called Fagopyrum cumosum (Trev.) Meisn, whose rhizome was considered as folk medicine for clearing away heat and toxic materials, expelling pus and removing blood stasis [3,4,5]. Until recently, some biological activities of F. dibotrys, including anti-oxidant, anti-tumor, anti-inflammatory, anti-bacterial [6,7,8], and so on have been reported, but anti-influenza activity is unknown.
The Q-Exactive system with the its high resolving power performance easily combines with ultra-high performance liquid chromatography (UHPLC). UHPLC-Q-Exactive Orbitrap high resolution mass spectrometry (HRMS) can rapidly detect hundreds of components in complex compound mixtures from plants with short running times [9]. Similarly, molecular docking is a reliable and efficient tool for discovering or designing novel drugs used to screen biological chemical compounds [10,11,12,13]. In the present work (see Figure 1 for a flowchart of the protocol used), four F. dibotrys extracts (ethyl acetate (EA), petroleum ether (P), ethanol (E), and water (W)) were explored in a neuraminidase (NA) activity assay, with the components of the best extract being further identified by UHPLC-Q-Exactive Orbitrap HRMS. To further validate the NA inhibitory activity of F. dibotrys, eight components were docked to the NA inhibition target using molecular docking technology and tested in NA inhibition experiments. Based on the theory that NA is an important target to screen the anti-influenza virus drugs due to the fact it has the essential enzyme activity for virus replication and NA inhibitors are recognized as an effective drugs against influenza A and B by the World Health Organization [14], this research will provide a new direction and basic information for novel anti-influenza virus drug discovery.

2. Result and Discussion

2.1. Influenza Virus Neuraminidase (NA) Activity Assay of Four Extracts

NA has been considered as an important target to screen anti-influenza virus drugs. NA inhibitory activities of the four extracts are shown in Figure 2. They all indicated dose-dependent activity. The lower IC50 value implies a higher activity. Based on the IC50 values, two extracts are good and EA is the best one. The IC50 of EA and P are 149 and 182 µg/mL, respectively. The activity order is EA > P > E > W.

2.2. Identification of Chemical Compositions of EA Extract by UHPLC-Q-Exactive

The identification of the chemical components of the F. dibotrys EA extract was investigated using UHPLC-Q-Exactive HRMS. Based on the retention time, standard substances, molecular ions, and major fragments were observed in MS spectra, followed by a search of an online database (METLIN) and literature reports, wherein 32 chemical structures were tentatively identified and were definitely classified into four groups: flavonoids, tannins, organic acids, and others. Figure 3 and Figure 4 show the EA extract base peak chromatogram (BPC) and the chemical structures of the main identified compounds, respectively. The identified compounds, retention time, molecular formula, exact mass, experimental mass, the major fragments, and references are listed in Table 1.

2.2.1. Flavonoids

Thirteen flavonoid components were identified [15,16,17], and among them six peaks (12, 13, 15, 24, 25 and 28) were matched with standard compounds. Peaks 12 and 13, a pair of isomers with a m/z 289 molecular ion and a fragment ion of m/z 245 [M − H − CO2], was proposed to be (−)epicatechin and (+)-catechin, respectively. Peaks 29 and 31, both with a m/z 285 molecular ion [M − H], were identified as luteolin and kaempferol, respectively, from a comparison with an online database (METLIN) and literature data. Peak 3 was tentatively identified as 5,7-dimethoxyflavanone for the first time.

2.2.2. Tannins

The only tannin in this study, peak 9, with fragment ions of m/z 577 and 289 was proposed to be procyanidin B2 which was conformed using a standard.

2.2.3. Organic Acids

Twelve organic acid compounds were detected in the EA extract [3,18,19]. Among them, three peaks (2, 6, 14) were identified by comparison with standard compounds. Peak 10, with a molecular ion [M − H] at m/z 137, and a fragment at m/z 93 identified as [M − H − CO2] was proposed to be 4-hydroxybenzoic acid. Peaks 4, 8, and 23 were identified as vanillic acid, chlorogenic acid, and 3-hydroxy-4-methoxybenzoic acid, respectively. Peak 8 has a molecular ion at m/z 353, and the fragment ion of m/z 191 (M2) can be obtained when the ester bond is broken. The ions at 173 m/z and 154 were proposed to be [M2 − H − H2O] and [M2 − H − 2H2O]; these fragments were in accordance with literature reports. Peaks 1 and 7 were identified as succincic acid and ferulic acid. Peaks 14 and 18 were identified as caffeic acid and benzoic acid, respectively, with corresponding fragment ions at m/z 135 [M − H − CO2] and m/z 77 [M − H − CO2], from a comparison with an online database (METLIN) and literature data.

2.2.4. Other Compounds

Peak 11 was proposed to be 4-o-methyl-gallate, whose fragment ions were m/z 169 [M − H − CH3 − CO2], m/z 125 [M − CH3 − CO2] [20]. Peak 21 had a molecular ion at m/z 197, and its fragment ions at m/z 169 and 125 were identified as [ethyl gallate − CH3CH2], and [ethyl gallate − CH3CH2 − CO2], respectively. The three peaks 11, 19, 21 were confirmed using standard compounds and are consistent with previous reports [21].
Peak 5 was identified as glucosyringic acid, with a m/z 359 molecular ion; the fragment ion was [M − H − Glu]. The compound protocatechuic acid methyl ester at 6.23 min, showed m/z 167 and 149 [M − H − H2O] ions. Peak 32, the last compound, was proposed to be emodin with a fragment ion at m/z 225 [M − H − CO2].
This, a total of 32 compounds, including 13 flavonoids, one tannin, 12 organic acids, and others such as 4-o-methyl-gallate, glucosyringic acid, ethyl gallate, ellagic acid, protocatechuic acid methyl ester, and so on, were tentatively identified. Five compounds, including 5,7-dimethoxyflavanone, vanillic acid, 3-hydroxy-4-methoxybenzoic acid, ellagic acid, and glucosyringic acid, were found for the first time in F. dibotrys. Some of the same compounds, such as quercitrin, kaempferol, -epicatechin, protocatechuic acid, and chlorogenic acid, were previously reported in the genus Fagopyrum (Fagopyrums tataricum and Fagopyrums esculentum) [3].

2.3. In Silico Docking of Eight Chemical Compounds

One objective of this study was to compare its results and those of pharmacological neuraminidase assay experiments to confirm the activities of compounds in F. dibotrys. Eight main chemical compounds, such as procyanidin B2, rutin, hesperidin, quercitrin, eriodictyol, caffeic acid, (−)epicatechin, and (+)-catechin, were selected for this part of the study. They were docked to 3TI3 that was selected based on the PharmaDB target database. Based on free energy, a higher absolute value implies a higher biological activity. Four compounds had good NA inhibitory activity, and procyanidin B2 was the best one. The indicated docking results were procyanidin B2 > rutin > hesperidin> quercitrin > eriodictyol > caffeic acid > (−)epicatechin > catechin. Figure 5 shows the first four compounds’ binding mode with NA. The absolute values of INT can be seen from the Table S1 in supplementary.

2.4. Neuraminidase (NA) Experiment of the Main Chemical Compounds

Based on the above results of the influenza virus NA activity assay of the EA extract and eight main chemical compounds, NA experiments were conducted with the eight main chemical compounds. Oseltamivir acid was the positive control. Each component has different degrees of activity in the inhibition assay. Among them, rutin had the best effect and the order is rutin > hesperidin > procyanidin B2 > quercitrin > eriodictyol > epicatechin > catechin > caffeic acid, which is roughly similar to the in silico docking result. Figure 6 and Table 2 show the inhibition of NA activity and IC50 values of all the compounds.
According to the results from the computational approach and neuraminidase (NA) experiments, the first three compounds, rutin, hesperidin, and procyanidin B2, indeed have NA inhibitory effects. Based on this conclusion, F. dibotrys maybe have an anti-influenza virus effect.
Every year, deaths occur around the world because of the influenza virus, which has the highest morbidity among infectious diseases [22]. At present, the NA inhibitors are the first options in clinical practice against the disease. However, chemical drugs can easily cause side effects and drug-resistant virus. Thus, searching for new resources against the influenza virus is necessary and meaningful. In this paper, we demonstrated for the first time that F. dibotrys can cause certain NA inhibitory effects from three aspects (extracts, docking and single compounds). The present work would provide basic information and a new research direction for further further tests in vitro and clinical research on F. dibotrys.

3. Materials and Methods

3.1. Plant Material and Sample Preparation

Samples of F. dibotrys were collected in Dali, located in central Yunnan, China, in June 2012. The samples were identified by Professor Linfang Huang, and the voucher specimens (CMPB00359) were deposited in the Herbarium of the Chinese Academy of Medical Science & Peaking Union Medicinal College. Samples of dried F. dibotrys root were crushed to a fine powder in a pulverizer. One kg of powder was extracted by infusion with 2.5 L of petroleum ether for 24 h. Then, the residue was extracted with 80% ethanol using countercurrent extraction for three times and 2 h each time. The filtered extracted solutions were concentrated using a rotary evaporator to remove the ethanol solution. The concentrated solution was then successively extracted with ethyl acetate using the liquid-liquid extraction method, and the solvent was removed to obtain a dry form of the ethyl acetate fraction using a rotary evaporator. The residue was evaporated to dryness and extracted with water then evaporated to dryness, and the water extract was obtained. The four extracts were used for NA inhibition assays, and the best one was used for qualitative analysis by UPLC-Q-Exactive. The extract was dissolved in methanol at concentrations (w/v) of 5 mg/mL and filtered through 0.22 µm nylon micropore membranes before chemical characterization.

3.2. Chemicals and Standard Substances

LC-MS grade acetonitrile was purchased from Fisher Scientific (Beijing, China). De-ionized water was purified through a Milli-Q system (Millipore, Bedford, MA, USA). The analytical grade reagents used for extraction were obtained from Beijing Chemical Plant Co. Ltd. (Beijing, China). Gallic acid, ellagic acid, ethyl gallate, methyl-gallate, rutin, epicatechin, procyanidin B2, protocatechuic acid, quercitrin, hesperidin, eriodictyol, and caffeic acid were purchased from Chengdu Must Biotechnology Co. Ltd. (Chengdu, China). Oseltamivir acid was purchased from Medchem Express, LLC (Monmouth Junction, NJ, USA). Neuraminidase Inhibitors Screen Kit (NO. P0309) was purchased from Beyotime Institute of Biotechnology Co. Ltd. (Shanghai, China) and includes 10 mL buffer, 1 mL NA, 1 mL fluorescent substrate, and 1.2 mL Milli-Q water. Ninety six-well microplate reader (3925, Costar Company, Bethesda, MD, USA).

3.3. Software and Docking Studies

The protein crystal (PDB ID: 3ti3) was downloaded from the PDB database (http://www.rcsb.org/pdb) and docked using the Molecular Operating Environment (MOE) 2014.09 (Chemical Computing Group Inc., Montreal, QC, Canada).

3.4. UPLC-Q-Exactive Analysis

3.4.1. Liquid Chromatography

UHPLC analysis was performed using an Ultimate 3000 system (Dionex, Sunnyvale, CA, USA), connected to an online vacuum degasser, an autosampler, a quaternary pump, and a thermostatted column compartment. The chromatographic separation column was ACQUITY UPLC HSS T3, 2.1 mm × 100 mm, 1.7 µm (Waters, Milford, MA, USA) at 40 °C. The separation conditions contain a gradient elution using acetonitrile as phase A and aqueous formic acid 0.1% (v/v) as mobile phase B at a flow rate of 0.3 mL/min. The following gradient was applied: 0–1 min, 0% A; 1–10 min, 0–100% A; 10–10.1 min, 100–0% A and 10–10.1 min, 0% A. The injection volume was 2 µL, and the injection temperature was 15 °C.

3.4.2. Mass Spectrometry

Mass spectrometry was executed using a Q Exactive Orbitrap MS system (Thermo Fisher, Waltham, MA, USA) with a heated electrospray ionization source for the ionization of the target compounds under the negative mode. The following are operating parameters: auxiliary gas heater temp, 300 °C; spray voltage, 3.70 KV; capillary temp, 320 °C; auxiliary gas pressure, 10 arb; sheath gas pressure, 30 psi; scan modes, full MS (resolution 70,000), and scan range, 100–1500 m/z. The data were processed using the Xcalibur software (Thermo).

3.5. Neuraminidase (NA) Inhibition Assay

Oseltamivoir acid, four extracts and other eight compounds (all of them were tested as inhibitors) were dissolved in DMSO to give a 1 mg/mL solution. They were then diluted to 100 μg/mL and 200 μg/mL using buffer solution. The experiments were executed in a 96-well microplate reader using the procedure provided in the kit instructions. A reaction mixture containing 70 µL of reaction buffer solution, 10 µL of NA and 10 µL of inhibitors with concentrations of 25, 50, 100, 150 and 200 μg/mL diluted from mother liquor, were added to each well respectively. Every concentration existed in three holes and they were added to 10 µL Mill-Q water for each wells’ buck were 90 µL. Vibration mixing was performed for approximately 1 min and incubation for 2 min at 37 °C, so that the NA and inhibitors react sufficiently. Afterwards, 10 µL of fluorescent substrate was added to produce a total of 100 µL reaction mixture. The whole mixture was completely mixed by vibration for 1 min, and the plate was incubated for 30 min at 37 °C. The fluorescence was read using a microplate spectrophotometer (Molecular Devices, Gemini EM, Shanghai, China) with 322 nm of excitation wavelength and 450 nm of emission wavelength. The experiment was repeated three times. Oseltamivoir acid was used as a positive control. The inhibition (%) was calculated using the formula:
NA Inhibitory activity (%) = [1 − (Fs − F0)/(Fm − F0)] × 100%
Fs was fluorescence intensity of inhibitors in the presence of the sample, F0 was the fluorescence intensity of the blank control and Fm was the fluorescence intensity of the negative control. The 50% inhibitory concentration (IC50) was analyzed by probit regression in SPSS (version 21, IBM SPSS, Chicago, IL, USA).

3.6. Statistical Analysis

NA inhibition assay was conducted in triplicate. Graph Pad Prism 6 (GraphPad, San Diego, CA, USA) and SPSS 21 were used for the statistical analysis of the data.

4. Conclusions

The NA inhibitory effect of F. dibotrys was revealed for the first time. An advanced UHPLC-Q-Exactive method and a novel computational approach were developed to successfully elucidate the complicated chemical composition of F. dibotrys. A total of 32 compounds, including 13 flavonoids, one tannin, 12 organic acids, and six other compounds, were characterized. Among them, five compounds were reported for the first time in F. dibotrys. This work showed that UHPLC-Q-Exactive Orbitrap HRMS was a rapid and reliable tool for complex plant chemical component analysis and that F. dibotrys had NA inhibitory activity based on molecular docking. Further research is essential to explore the molecular mechanisms. Our laboratory group will further explore these effects through in anti-influenza virus experiments. This study provided scientific evidence and a new direction for future research on improving the resource efficiency of F. dibotrys.

Supplementary Materials

Supplementary materials are available online.

Acknowledgments

The study was supported by grants from the National Natural Science Foundation of China (81473315), Public welfare scientific research project of State Administration of traditional Chinese Medicine (201507004-2-1) and CAMS Innovation Fund for Medical Sciences(CIFMS) (no. 2016-I2M-3-015).

Author Contributions

Linfang Huang and Haibo Liu conceived and designed the experiments; Ai-Lin Liu and Jin-Hua Li performed the experiments; Yu Cao and Xiang Zhang analyzed the data; Xiang Zhang wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhu, Q.L.; Guo, T.Y.; Sui, S.Z.; Liu, G.D.; Lei, X.H.; Luo, L.L.; Li, M.Y. Molecular cloning and characterization of a novel isoflavone reductase-like gene (FcIRL) from high flavonoids-producing callus of Fagopyrum cymosum. Acta Pharm. Sin. 2009, 44, 809. [Google Scholar]
  2. Liang, C.; Yuan, J.P.; Ding, T.; Yan, L.; Ling, L.; Zhou, X.F.; Zeng, Y.Q. Neuroprotective Effect of Fagopyrum dibotrys Extract against Alzheimer’s Disease. Evid. Based Complement. Altern. Med. 2017, 2017, 1–9. [Google Scholar] [CrossRef] [PubMed]
  3. Rui, J.; Li, H.Q.; Hu, C.L.; Jiang, Y.P.; Qin, L.P.; Zheng, C.J. Phytochemical and Pharmacological Profiles of Three Fagopyrum Buckwheats. Int. J. Mol. Sci. 2016, 17, 589. [Google Scholar] [CrossRef]
  4. Wang, K.J.; Zhang, Y.J.; Yang, C.R. Antioxidant phenolic constituents from Fagopyrum dibotrys. J. Ethnopharmacol. 2005, 99, 259–264. [Google Scholar] [CrossRef] [PubMed]
  5. Chen, C.; Li, A. Transcriptome Analysis of Differentially Expressed Genes Involved in Proanthocyanidin Accumulation in the Rhizomes of Fagopyrum dibotrys and an Irradiation-Induced Mutant. Front. Physiol. 2016, 7, 100. [Google Scholar] [CrossRef] [PubMed]
  6. Li, C.; Feng, Z.; Bai, Y.; Chen, H.; Zhao, H.; Wu, Q. Molecular cloning and prokaryotic expression of phenylalanine ammonia-lyase gene FdPAL from Fagopyrum dibotrys. China J. Chin. Mater. Med. 2011, 36, 3238–3243. [Google Scholar]
  7. Ma, J.; Wang, B.; Dai, Y.; Sui, S.Z.; Li, M.Y. Cloning and expression analysis of leucoanthocyanidin reductase gene in Fagopyrum dibotrys. Acta Pharm. Sin. 2012, 47, 953. [Google Scholar]
  8. Zhang, Y.; He, P.; Zhang, C. Influences of enhanced UV-B radiation and drought stress on biomass accumulation and allocation of Fagopyrum dibotrys. Zhongguo Zhong Yao Za Zhi 2011, 36, 2032–2037. [Google Scholar] [PubMed]
  9. Li, J.; Kuang, G.; Chen, X.; Zeng, R. Identification of Chemical Composition of Leaves and Flowers from Paeonia rockii by UHPLC-Q-Exactive Orbitrap HRMS. Molecules 2016, 21, 947. [Google Scholar] [CrossRef] [PubMed]
  10. Lei, Q.; Liu, H.; Peng, Y.; Xiao, P. In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui). Chin. Med. 2015, 10, 37. [Google Scholar] [CrossRef] [PubMed]
  11. Yi, F.; Sun, L.; Xu, L.J.; Peng, Y.; Liu, H.B.; He, C.N.; Xiao, P.G. In silico Approach for Anti-Thrombosis Drug Discovery: P2Y1R Structure-Based TCMs Screening. Front. Pharmacol. 2016, 7, 531. [Google Scholar] [CrossRef] [PubMed]
  12. Liu, J.-Q.; Dai, S.-X.; Zheng, J.-J.; Guo, Y.-C.; Li, W.-X.; Li, G.-H.; Huang, J.-F. The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds. Sci. Rep. 2017, 7, 41406. [Google Scholar] [CrossRef] [PubMed]
  13. Yi, F.; Tan, X.L.; Yan, X.; Liu, H.B. In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach. Chin. Med. 2016, 11, 42. [Google Scholar] [CrossRef] [PubMed]
  14. Li, J.; Yang, X.; Huang, L. Anti-Influenza Virus Activity and Constituents. Characterization of Paeonia delavayi Extracts. Molecules 2016, 21, 1133. [Google Scholar] [CrossRef] [PubMed]
  15. He, C.; Peng, B.; Dan, Y.; Peng, Y.; Xiao, P. Chemical taxonomy of tree peony species from China based on root cortex metabolic fingerprinting. Phytochemistry 2014, 107, 69–79. [Google Scholar] [CrossRef] [PubMed]
  16. Jiang, S.; Liu, Q.; Xie, Y.; Zeng, H.; Zhang, L.; Jiang, X.; Chen, X. Separation of five flavonoids from tartary buckwheat (Fagopyrum tataricum (L.) Gaertn) grains via off-line two dimensional high-speed counter-current chromatography. Food Chem. 2015, 186, 153–159. [Google Scholar] [CrossRef] [PubMed]
  17. Kim, S.J.; Zaidul, I.S.; Suzuki, T.; Mukasa, Y.; Hashimoto, N.; Takigawa, S.; Noda, T.; Matsuura-Endo, C.; Yamauchi, H. Comparison of phenolic compositions between common and tartary buckwheat (Fagopyrum) sprouts. Food Chem. 2008, 110, 814–820. [Google Scholar] [CrossRef] [PubMed]
  18. Quettier-Deleu, C.; Gressier, B.; Vasseur, J.; Dine, T.; Brunet, C.; Luyckx, M.; Cazin, M.; Cazin, J.C.; Bailleul, F.; Trotin, F. Phenolic compounds and antioxidant activities of buckwheat (Fagopyrum esculentum Moench) hulls and flour. J. Ethnopharmacol. 2000, 72, 35–42. [Google Scholar] [CrossRef]
  19. Xiao, C.; Wu, M.; Chen, Y.; Zhang, Y.; Zhao, X.; Zheng, X. Revealing metabolomic variations in Cortex Moutan from different root parts using HPLC-MS method. Phytochem. Anal. 2015, 26, 86–93. [Google Scholar] [CrossRef] [PubMed]
  20. Nalewajko-Sieliwoniuk, E.; Malejko, J.; Mozolewska, M.; Wolyniec, E.; Nazaruk, J. Determination of polyphenolic compounds in Cirsium palustre (L.) extracts by high performance liquid chromatography with chemiluminescence detection. Talanta 2015, 133, 38–44. [Google Scholar] [CrossRef] [PubMed]
  21. Shaheen, N.; Lu, Y.; Geng, P.; Shao, Q.; Wei, Y. Isolation of four phenolic compounds from Mangifera indica L. flowers by using normal phase combined with elution extrusion two-step high speed countercurrent chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2017, 1046, 211–217. [Google Scholar] [CrossRef] [PubMed]
  22. Yang, X.Y.; Liu, A.L.; Liu, S.J.; Xu, X.W.; Huang, L.F. Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza. Molecules 2016, 21, 1138. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
Figure 1. The flowchart of the paper.
Figure 1. The flowchart of the paper.
Molecules 22 01998 g001
Figure 2. NA inhibitory activity of four extracts of F. dibotrys. EA: ethyl acetate fraction; P: petroleum ether fraction; E: ethanol fraction; W: water fraction.
Figure 2. NA inhibitory activity of four extracts of F. dibotrys. EA: ethyl acetate fraction; P: petroleum ether fraction; E: ethanol fraction; W: water fraction.
Molecules 22 01998 g002
Figure 3. Base peak chromatogram (BPC) of the ethyl acetate fraction (EA) of F. dibotrys (negative ion mode).
Figure 3. Base peak chromatogram (BPC) of the ethyl acetate fraction (EA) of F. dibotrys (negative ion mode).
Molecules 22 01998 g003
Figure 4. Chemical structures of the main identified compounds in the EA extract from F. dibotrys.
Figure 4. Chemical structures of the main identified compounds in the EA extract from F. dibotrys.
Molecules 22 01998 g004
Figure 5. Predicted binding mode of four compounds with NA in three-dimensions (3D) and two-dimensions (2D) (AD) rutin, hesperidin, procyanidin B2 and quercitrin with three-dimensional structure; (ad) rutin, hesperidin, procyanidin B2 and quercitrin with two-dimensional structure).
Figure 5. Predicted binding mode of four compounds with NA in three-dimensions (3D) and two-dimensions (2D) (AD) rutin, hesperidin, procyanidin B2 and quercitrin with three-dimensional structure; (ad) rutin, hesperidin, procyanidin B2 and quercitrin with two-dimensional structure).
Molecules 22 01998 g005
Figure 6. Inhibition of NA activity by various components of EA extract of F. dibotrys. ((A), rutin; (B), hesperidin; (C), procyanidin B2; (D), quercitrin; (E), eriodictyol; (F), (−)-epicatechin; (G), (+)-catechin; (H), caffeic acid).
Figure 6. Inhibition of NA activity by various components of EA extract of F. dibotrys. ((A), rutin; (B), hesperidin; (C), procyanidin B2; (D), quercitrin; (E), eriodictyol; (F), (−)-epicatechin; (G), (+)-catechin; (H), caffeic acid).
Molecules 22 01998 g006
Table 1. Thirty-two chemical constituents identified in the ethyl acetate fraction (EA) of F. dibotrys extracts using UHPLC-Q-Exactive.
Table 1. Thirty-two chemical constituents identified in the ethyl acetate fraction (EA) of F. dibotrys extracts using UHPLC-Q-Exactive.
PeakAssigned IdentifyRt (min)Formula IonsCalculated (m/z) Experimental (m/z)Fragment IonsReference Sources
1succinic acid2.65C4H6O4117.01824117.0178473[3]
2gallic acid4.13C7H6O5169.01315169.01306125[15]
35,7-dimethoxyflavanone4.16C17H15O4282.08866282.08411268First report in F. dibotrys
4Vanillic acid4.56C8H8O4167.03389167.03386149First report in F. dibotrys
5glucosyringic acid4.61C15H20O10359.09727359.09808197First report in F. dibotrys
6protocatechuic acid4.69C7H6O4153.01824153.0181109[3]
7ferulic acid4.84C10H10O4193.04954193.04948178[13]
8chlorogenic acid4.93C16H18O9353.08671353.08743191[3]
9procyanidin B25.08C30H26012577.13405577.13464289[3]
104-hydroxybenzoic acid5.15C7H6O3137.02332137.0230393[3]
114-o-methyl-gallate5.20C8H8O5183.0288183.02884169,125[12]
12(−)epicatechin5.27C15H14O6289.07066289.07141245[3]
13(+)-catechin5.27C15H14O6289.07066289.07141245[2]
14caffeic acid5.32C9H8O4179.03389179.03378135[13]
15rutin5.53C27H30O16609.14501609.14612301[2,3]
16kaempferol-3-o-rutinoside5.55C27H30O15593.1501593.15076 [3]
17hyperoside5.69C21H20O12463.0871463.08832301,271[5]
18benzoic acid5.71C7H6O2121.02841121.0280577[3]
19ellagic acid5.72C14H6O8300.99789300.99881299.01556First report in F. dibotrys
204-Hydroxycinnamic acid5.82C9H8O3163.03897163.03893146,119-
21ethyl gallate5.83C9H10O5197.04445197.0446169,153[14]
22Syringic acid5.84C9H10O5197.04445197.04466153[13]
233-hydroxy-4-methoxybenzoic acid5.93C8H8O4167.03389167.03386 First report in F. dibotrys
24quercitrin5.95C21H20O11447.09219447.09296301[2,3]
25hesperidin6.00C28H34O15609.1814609.18292301[3]
263′′,5′-dimethoxy-4′,5,7-trihydroxyflavone6.06C17H14O7329.06558329.06671 -
27protocatechuic acid methyl ester6.23C8H8O4167.03389167.03389149[3]
28eriodictyol6.79C15H12O6287.05501287.05585 -
29luteolin6.92C15H10O6285.03936285.04044133[3]
30isorhamnetin7.02C16H12O7315.04993315.05099300-
31kaempferol7.13C15H10O6285.03936285.04059255[3]
32emodin9.22C15H10O5269.04445269.04535241[2]
Table 2. The IC50 values of 8 main chemical compounds in F. dibotrys on neuraminidase (NA) inhibition assay.
Table 2. The IC50 values of 8 main chemical compounds in F. dibotrys on neuraminidase (NA) inhibition assay.
CompoundsIC50 (μM)Compound Group
Rutin216.363 ± 4.4627Flavonoids
Hesperidin287.179 ± 3.0712Flavonoids
Procyanidin B2338.298 ± 12.7432Tannins
Quercitrin384.946 ± 5.2333Flavonoids
Eriodictyol634.116 ± 5.18442Flavonoids
(−)-Epicatechin650.370 ± 10.6953Flavonoids
(+)-Catechin660.377 ± 6.5982Flavonoids
Caffeic Acid796.218 ± 12.4298Organic acids
Oseltamivir Acid275.068 ± 4.4973

Share and Cite

MDPI and ACS Style

Zhang, X.; Cao, Y.; Li, J.; Liu, A.; Liu, H.; Huang, L. Neuraminidase Inhibitory Activity and Constituent Characterization of Fagopyrum dibotrys. Molecules 2017, 22, 1998. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22111998

AMA Style

Zhang X, Cao Y, Li J, Liu A, Liu H, Huang L. Neuraminidase Inhibitory Activity and Constituent Characterization of Fagopyrum dibotrys. Molecules. 2017; 22(11):1998. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22111998

Chicago/Turabian Style

Zhang, Xiang, Yu Cao, Jinhua Li, Ailin Liu, Haibo Liu, and Linfang Huang. 2017. "Neuraminidase Inhibitory Activity and Constituent Characterization of Fagopyrum dibotrys" Molecules 22, no. 11: 1998. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22111998

Article Metrics

Back to TopTop